Bedankt voor het vertrouwen het afgelopen jaar! Om jou te bedanken bieden we GRATIS verzending (in België) aan op alles gedurende de hele maand januari.
- Afhalen na 1 uur in een winkel met voorraad
- In januari gratis thuislevering in België
- Ruim aanbod met 7 miljoen producten
Bedankt voor het vertrouwen het afgelopen jaar! Om jou te bedanken bieden we GRATIS verzending (in België) aan op alles gedurende de hele maand januari.
- Afhalen na 1 uur in een winkel met voorraad
- In januari gratis thuislevering in België
- Ruim aanbod met 7 miljoen producten
Estimands in Clinical Trials
A Practical Guide
€ 137,45
+ 274 punten
Omschrijving
This book provides a comprehensive, up-to-date, and practical introduction to the estimand framework and its application in clinical trials. Since its introduction by the International Council for Harmonisation (ICH) through the E9(R1) guideline in 2019, the estimand framework has led to a significant shift in the design, conduct, analysis, and interpretation of clinical trials. By explicitly aligning trial objectives with the clinical question of interest and by carefully accounting for intercurrent events the framework facilitates greater transparency and interpretability of trial results. In recent years, its adoption has supported improved scientific and regulatory dialogue, more targeted trial designs and analysis methods, and a better understanding of treatment effects across drug development programs.
This book reflects both the conceptual underpinnings of the estimand framework and the growing body of experience gained by the scientific and regulatory community since the release of the ICH E9(R1) guideline. Emphasis is placed on practical implementation across a wide range of clinical and therapeutic settings.
- Part I introduces the core concepts of the framework and offers detailed guidance on how to describe estimands in clinical trial protocols and related documents.
- Part II presents a wide range of case studies from various therapeutic areas to support practical implementation.
- Part III summarizes estimand-related content from regulatory guidelines across different indications.
- Part IV describes statistical analysis methods and approaches for handling missing data across continuous, binary, recurrent, and time-to-event endpoints.
- Part V explores the use of the estimand framework in a variety of clinical trial settings.
Designed for a broad audience of professionals and students involved in clinical research, this book will be particularly valuable for those engaged in the design, conduct, and analysis of clinical trials across the drug development lifecycle. It serves both as a structured introduction for those new to the field and a detailed reference for experienced professionals. Whether for academic study or practical implementation, this book is an essential resource for advancing the estimand framework and promoting more robust, informative clinical trials.
Specificaties
Betrokkenen
- Uitgeverij:
Inhoud
- Aantal bladzijden:
- 486
- Taal:
- Engels
- Reeks:
Eigenschappen
- Productcode (EAN):
- 9783032021915
- Verschijningsdatum:
- 26/12/2025
- Uitvoering:
- Hardcover
- Formaat:
- Genaaid
- Afmetingen:
- 155 mm x 235 mm
Alleen bij Standaard Boekhandel
+ 274 punten op je klantenkaart van Standaard Boekhandel
SOLDEN
Beoordelingen
We publiceren alleen reviews die voldoen aan de voorwaarden voor reviews. Bekijk onze voorwaarden voor reviews.